Tag - shionogi

 
Menu
Search
 
May 09, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

SHIONOGI

Japan Times
JAPAN / Science & Health
Nov 30, 2021
Japanese drugmaker Shionogi considers developing vaccine for omicron variant
The company is currently conducting a final clinical trial of its COVID-19 vaccine, aiming to make it available in March.
Japan Times
JAPAN / Explainer
Oct 20, 2021
Oral drug molnupiravir seen as 'trump card' in Japan's battle against COVID-19
The treatment developed by Merck could receive fast-track approval by the end of the year, and other oral drugs to fight the coronavirus are not far behind.
Japan Times
BUSINESS / Companies
Oct 8, 2021
COVID-19 pill sales could hit $2 billion, drugmaker Shionogi says
Competition to snag a piece of the COVID pill market is fierce, as the world adjusts to the virus being endemic.
Japan Times
JAPAN
Aug 6, 2021
Japan drugmaker Shionogi to seek approval for oral COVID-19 drug
Designed to prevent moderate COVID-19 symptoms from worsening, the drug could facilitate at-home treatment and ease the strain on hospitals.
Japan Times
JAPAN / Science & Health
Jul 7, 2021
Japanese drugmaker Shionogi to double COVID-19 vaccine supply to 60 million
The vaccine, which could be the first domestically developed in Japan, can be effective even with half the amount previously deemed necessary, company officials said.
Japan Times
JAPAN
Apr 1, 2021
New recruits mark first day at work, many joining ceremonies online
Last year many events marking the start of the new business year were canceled due to the spread of the virus that causes COVID-19, but this year some have resumed.
Japan Times
BUSINESS
Dec 11, 2020
Why Japan is largely a spectator in the coronavirus vaccine race
A total of 52 vaccine candidates were in clinical evaluation worldwide as of Tuesday, of which only one was Japanese.
Japan Times
JAPAN / Science & Health
Oct 29, 2020
Japan's Shionogi readies COVID-19 vaccine for December trial
The firm plans to put its vaccine candidate into Phase 1 clinical trials in December and shift into Phase 2 by January.
Japan Times
BUSINESS / Companies
Oct 23, 2020
Japanese drug firm Shionogi hit by cyberattack and data breach
Japanese pharmaceutical firm Shionogi & Co. said Thursday that its Taiwanese subsidiary was hit by a cyberattack earlier this month leading to a data breach, although no information regarding the novel coronavirus vaccine it is currently developing was leaked.
Japan Times
BUSINESS / Companies
Jun 22, 2020
Japan drugmaker to tie up with universities to develop new test method for coronavirus
Japanese pharmaceutical company Shionogi & Co. said Monday that it will collaborate with universities in the country to put into practical use a new testing method for the novel coronavirus.
Japan Times
JAPAN / Science & Health / FOCUS
Jun 3, 2020
Japan pushes homegrown coronavirus vaccines to secure supply
The government is concerned that foreign vaccines may be not widely available in the nation.
Japan Times
BUSINESS
May 8, 2020
Drugmaker Shionogi rushing to launch coronavirus vaccine in 2021
It is rare to study production before getting the results of clinical trials, but the Japanese drugmaker wants a vaccine on the market as fast as possible.
Japan Times
BUSINESS
Apr 27, 2020
Shionogi to develop coronavirus vaccine, with trials eyed for this year
Shionogi & Co. said Monday it will develop a vaccine for the novel coronavirus with the aim of starting clinical trials this year.
Japan Times
JAPAN / Science & Health
Feb 24, 2018
One-dose flu drug Xofluza gets nod from health ministry
Osaka-based drugmaker Shionogi & Co. has announced that the health ministry gave it approval to manufacture and market its new flu drug Xofluza, which requires only a single dose regardless of age.
Japan Times
BUSINESS / Companies
Sep 29, 2017
Opioids demand rises in Japan as seniors use drugs to ease pain and improve quality of life
Selling painkillers in Japan used to be like pulling teeth. That was until baby boomers discovered how analgesics could take the sting from arthritis, diabetic nerve damage and the ravages of cancer.
Tokuryū, a new crime menace in Japan, emerges from the shadows
The National Police Agency coined the term "tokuryū" to classify individuals involved in dark part time jobs and quasi-gangsters, using the words "tokumei" (anonymous) and "ryūdo" (fluid) to reflect their characteristics.
Thanks, tourists. Views of Mount Fuji are now blocked.
Tourists pose in front of a convenience store with Mount Fuji on Friday in the town of Fujikawaguchiko, Yamanashi Prefecture. Local residents are upset over littering, overcrowding and the inconvenience caused by the visitors.
Is Modi’s party heading for a stunning election loss?
Indian Prime Minister Narendra Modi's campaign tactics have escalated, including anti-Muslim rhetoric and fearmongering, reflecting his ruling party's desperation.
Two more arrested over brutal murder of couple in Tochigi
A vehicle carrying Seiha Sekine, the 32-year-old common-law husband of the deceased Tokyo couple's first daughter, leaves a police station in Tokyo's Shinagawa Ward on Tuesday.
After blockbuster boxing victory, what next for ‘Monster’ Inoue?
Naoya Inoue celebrates his victory over Luis Nery in their IBF-WBA-WBC-WBO super bantamweight title boxing match at Tokyo Dome on Monday.
Stormy seas ahead as Beijing and Manila trade barbs over secret deal
Philippine Marines wave to Philippine Navy personnel and the media during a resupply mission at their military outpost, the BRP Sierra Madre, a warship run aground in the disputed Second Thomas Shoal in 1999, in the South China Sea, in March 2014.
Unlike 10 years ago, Japan's new security bill sparks little debate
The Lower House starts discussing a security clearance bill on April 19 in Tokyo.
After blockbuster boxing victory, what next for ‘Monster’ Inoue?
Naoya Inoue celebrates his victory over Luis Nery in their IBF-WBA-WBC-WBO super bantamweight title boxing match at Tokyo Dome on Monday.
Xi bristles as Macron and von der Leyen urge China to do more on Ukraine
French President Emmanuel Macron, Chinese leader Xi Jinping and European Commission chief Ursula von der Leyen walk after their meeting in Paris on Monday.
How a Japanese scientist is turning the climate crisis into music
A screencap of a performance of Hiroto Nagai's “String Quartet No. 1 ‘Polar Energy Budget’” by the PRT Quartet

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Rows of irises resemble a rice field at the Peter Walker-designed Toyota Municipal Museum of Art.
The 'outsiders' creating some of Japan's greenest spaces
By Stephen Mansfield

SUSTAINABLE JAPAN

Vol. 35: Travel in time — and stay there
Vol. 35: Travel in time — and stay there

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER